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ABSTRACT: The citrate transporter CitS of Klebsiella pneumoniae is a secondary transporter that transports
citrate in symport with two sodium ions and one proton. Treatment of CitS with the alkylating agent
N-ethylmaleimide resulted in a complete loss of transport activity. Treatment of mutant proteins in which
the five endogenous cysteine residues were mutated into serines in different combinations revealed that
two cysteine residues located in the C-terminal cytoplasmic loop, Cys-398 and Cys-414, were responsible
for the inactivation. Labeling with the membrane impermeable methanethiosulfonate derivatives MTSET
and MTSES in right-side-out membrane vesicles showed that the cytoplasmic loop was accessible from
the periplasmic side of the membrane. The membrane impermeable but more bulky maleimide AmdiS
did not inactivate the transporter in right-side-out membrane vesicles. Inactivation by N-ethylmaleimide,
MTSES, and MTSET was prevented by the presence of the co-ion Na+. Protection was obtained upon
binding 2 Na+, which equals the transport stoichiometry. In the absence of Na+, the substrate citrate had
no effect on the inactivation by permeable or impermeable thiol reagents. In contrast, when subsaturating
concentrations of Na+ were present, citrate significantly reduced inactivation suggesting ordered binding
of the substrate and co-ion; citrate is bound after Na+. In the presence of the proton motive force, the
reactivity of the Cys residues was increased significantly for the membrane permeable N-ethylmaleimide,
while no difference was observed for the membrane impermeable thiol reagents. The results are discussed
in the context of a model for the opening and closing of the translocation pore during turnover of the
transporter.
The sodium-ion dependent citrate transporter CitS of
Klebsiella pneumoniae transports divalent citrate in symport
with two sodium ions and one proton (1, 2). The transporter
functions in the anaerobic citrate degradation pathway of K.
pneumoniae and is encoded in an operon together with two
other enzymes of the pathway, citrate lyase and the primary
sodium ion pump, oxaloacetate decarboxylase (3). The citS
gene encodes a highly hydrophobic protein of 446 amino
acid residues and a predicted molecular mass of 47 557 Da
(4). CitS belongs to the family of 2-hydroxycarboxylate
transporters (2HCT)1 that contains secondary transporters
exclusively found in bacteria (5). Substrates of the transport-
ers in the family share a 2-hydroxycarboxylate motif like in
citrate, malate, and lactate. The family contains sodium ion
symporters (CitS, MaeN of Bacillus subtilis) and proton
symporters (CimH of B. subtilis, MaeP of Streptococcus
boVis) but also precursor/product exchangers (CitP of Leu-
conostoc mesenteroides, MleP of Lactococcus lactis, CitW
of K. pneumoniae) (6-11). The citrate/lactate exchanger CitP
and the malate/lactate exchanger MleP found in lactic acid
bacteria are involved in secondary proton motive force
generation (10, 12, 13).
Studies on the membrane topology of CitS revealed that
the protein contains 11 transmembrane segments (TMSs) that
traverse the membrane in a zigzag fashion with the N- and
C-terminus on the cytoplasmic and periplasmic face of the
membrane, respectively (14-16). In the secondary structure
model (Figure 1), the N-terminal half is separated from the
C-terminal half by a long cytoplasmic loop that is observed
in many transporters of this type. Three other loops are
considerably longer than found usually in bacterial transport-
ers, and it was speculated that they may have a role in
structure and/or function of the transporter (16). The loop
between TMS V and VI constitutes a hydrophobic segment
termed Vb that is long enough to span the membrane but is
translocated into the periplasm during insertion. The cyto-
plasmic loop between TMS VIII and IX forms an amphipatic
helix (AH) that is believed to play a role in the co-insertion
of the two adjacent TMSs (17). Finally, the cytoplasmic loop
between TMS X and XI, here called region Xa, forms
(together with segment Vb) one of the two most conserved
regions in the family and is suspected to play an important
role in substrate binding. Chimeric transporters in which the
46 C-terminal residues containing the Xa region of the CitP
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and MleP proteins were exchanged showed that this part
constitutes part of the substrate binding pocket (18). More-
over, a conserved arginine residue at the cytoplasmic side
of TMS XI was shown to be essential in CitS of K.
pneumoniae (Arg-428; unpublished), in CitP of L. me-
senteroides (Arg-425; (19)), and in CimH of B. subtilis (Arg-
432; (20)). The broad specificity of the exchangers in the
family allowed for the identification of Arg-425 of CitP as
the residue that directly interacts with one of the carboxylate
groups on the substrates (18, 21). The position of the
conserved arginine residue in the model suggests that the
binding site in this family of transporters is located closely
at the cytoplasm/membrane interface.
Recently, we showed that conserved residues Arg-420 and
Glu-428 in the Xa region of CimH of B. subtilis were
accessible from the periplasmic side of the membrane by
membrane impermeable reagents (20). It was suggested that
a water-filled substrate translocation pathway would extend
all the way to the cytoplasmic loop, or alternatively, region
Xa would form a reentrant looplike structure similarly as
reported for the glutamate transporters GltT of Bacillus
stearotermophilus and GLT-1 in the central nervous system
(22, 23). Here, we confirm and extend the observations made
with CimH of B. subtilis by showing that two nonconserved
Cys residues in region Xa of CitS of K. pneumoniae are
accessible from the periplasmic side of the membrane. The
importance of the region is demonstrated by showing that
the accessibility of the residues is directly linked to the
translocation event. The accessibility provides an assay for
different conformational states of the protein during turnover.
EXPERIMENTAL PROCEDURES
Bacterial Strains, Media, and Growth Conditions. Es-
cherichia coli strains DH5R and ECOMUT2 (24) were
routinely grown in Luria Bertani Broth (LB) medium at
37 °C under continuous shaking at 150 rpm. When appropri-
ate, antibiotics such as ampicillin and chloramphenicol
(ECOMUT2 strain) were added at a final concentration of
50 and 30 íg/mL, respectively.
All genetic manipulations were done in E. coli DH5R
while the CitS protein was expressed in E. coli ECOMUT2
harboring plasmid pBADCitS that contains the gene coding
for CitS with an N-terminal His-tag. Expression of CitS was
induced for 1 h by adding 0.1% arabinose when the optical
density of the culture measured at 660 nm (OD660) was 0.6.
Citrate metabolism was detected as blue colonies on Sim-
mons citrate agar indicator plates (Difco). The host E. coli
ECOMUT2 grew poorly without change of color (white
colonies) on Simmons agar plates.
Construction of pBADCitS and the Cysteine Mutants of
CitS. Plasmid pBADCitS was constructed by recloning the
citS gene (NcoI/XbaI) from plasmid pHisCitS (15) into the
pBAD24 vector (25) as follows. Plasmid pGltThisIII is
pBAD24 containing the gltT gene coding for glutamate
transporter of B. stearothermophilus (24). The gltT gene was
cut out from the plasmid using the NcoI and XbaI restriction
enzymes and replaced with the citS gene. The resulting
plasmid codes for the CitS protein with an N-terminal His-
tag. Expression of the gene is under control of the arabinose
promoter.
Cysteine mutants of CitS were constructed by PCR using
the QuickChange Site-Directed Mutagenesis Kit (Stratagene,
La Jolla, CA). Plasmid pHisCitS was used as the template.
All mutants were sequenced (Baseclear, Leiden, The Neth-
erlands) to confirm the presence of the desired mutations
and recloned into the pBAD24 vector as described above.
Preparation of the Right-Side-Out Membrane Vesicles.
Right-side-out (RSO) membrane vesicles were prepared by
the osmotic lysis procedure as described previously (26).
Membrane vesicles were resuspended in 50 mM potassium
phosphate (KPi) pH 6.0 and rapidly frozen and stored in
liquid nitrogen. Membrane protein concentration was deter-
mined by the DC Protein Assay Kit (Bio-Rad Laboratories,
Hercules, CA).
Transport Assay in RSO Membranes. Uptake was mea-
sured by the rapid filtration method. RSO membranes were
energized using the K-ascorbate/phenazine methosulfate
(PMS) electron donor system (27). Membranes were diluted
to a final concentration of 0.5 mg/mL into 50 mM KPi pH
6.0 containing 25 mM Na+ or as indicated otherwise, in a
total volume of 100 íL at 30 °C. Under a constant flow of
water-saturated air, and while stirring magnetically, 10 mM
K-ascorbate and 100 íM PMS (final concentration) were
added, and the proton motive force was allowed to develop
for 2 min. Then, [1,5-14C]-citrate (114 mCi/mmol Amersham
Pharmacia, Roosendaal, The Netherlands) was added to a
final concentration of 4.4 íM. The uptake was stopped by
the addition of 2 mL of ice-cold 0.1 M LiCl, followed by
immediate filtration over cellulose nitrate filters (0.45 ím
pore size). The filters were washed once with 2 mL of the
0.1 M LiCl solution and assayed for radioactivity. The
background was estimated by adding the radiolabeled
substrate to the vesicle suspension after the addition of 2
mL of ice-cold LiCl, immediately followed by filtering.
Specific activities of CitS wild type and mutants were
compared by correcting the uptake rates for the level of
expression of the proteins determined by Western blotting.
When indicated, experiments were carried out in low sodium
KPi buffer that contains at most 0.005% Na+, while standard
KPi buffers may contain up to 0.3%.
Treatment of Membranes with Thiol Reagents. RSO
membranes were treated with 1 mM NEM for 10 min and
with 0.25 mM AmdiS, 1 mM MTSEA, 2 mM MTSET, and
10 mM MTSES for 20 min in 50 mM KPi pH 7.0 at room
temperature. The treatment was stopped by addition of an
FIGURE 1: Membrane topology model of the CitS transporter
protein. The CitS protein contains 11 TMS indicated by the boxes.
The length of the loops more or less correlates with the number of
residues in the loop. Segment Vb corresponds to a hydrophobic
region that was predicted to be transmembrane. Loop Xa is one of
the best conserved regions in the protein family. The positions of
the five endogenous cysteine residues were indicated. Arg-428 in
TMS XI is believed to be involved in substrate binding.
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excess of 1 mM DTT in case of NEM and AmdiS, and 1-10
mM L-cysteine in case of the MTS-reagents, after which the
sample was diluted twice into 50 mM KPi pH 5.0. The
resulting suspension was pH 6.0 and was immediately used
to measure uptake activity.
The effect of sodium ions on the treatment was measured
by adding a mixture of NaCl and KCl yielding a total
concentration of 70 mM chloride. Upon dilution into the
assay mixture, the Na+ and K+ concentrations were adjusted
to 70 mM.
The effect of citrate was measured by adding the indicated
citrate concentrations from a 0.5 M stock solution adjusted
to pH 6.0. Following the treatment, the membranes were
washed twice with 600 íL of 50 mM KPi pH 6.0 by
centrifugation for 20 min in a Beckman OptimaTLX ultra-
centrifuge in a rotor TLA100.2 to remove the substrate.
Membranes were resuspended in 50 mM KPi pH 6.0
containing 25 mM Na+ and assayed for uptake activity. The
washing procedure resulted in a loss of 10-15% of the
uptake activity.
The effect of the pmf on the treatment was studied in RSO
membrane vesicles diluted in 50 mM KPi pH 7.0 to a final
concentration of 0.5 mg/mL and incubated for 2 min at
30 °C in the presence of Ascorbate/PMS as described above.
After 2 min NEM, MTSET, or MTSES was added to a final
concentration of 0.3, 1, and 3 mM, respectively, and
incubated for another 3 min. The membranes were washed
once as described above and resuspended in 50 mM KPi
pH 6.0.
Immunoblot Analysis. Samples containing 20 íg of total
membrane protein were loaded onto a 12.5% sodium dodecyl
sulfate-polyacrylamide gel (SDS-PAGE). After electro-
phoresis, the proteins were transferred to poly(vinylidene
difluoride) (PVDF) membranes (Roche Diagnostic GmbH,
Mannheim, Germany) by semi-dry electroblotting. The blots
were analyzed using monoclonal antibodies directed against
the His-tag (Dianova, Hamburg, Germany). Antibodies were
visualized using the Western-light chemiluminescence detec-
tion kit (Tropix, Bedford, MA). Expression levels were
estimated by determining the chemiluminescence intensity
of each band using a Lumi-Imager F1 imager (Roche
Diagnostic GmbH, Mannheim, Germany).
Materials. Sodium (2-sulfonatoethyl) methanethiosulfonate
(MTSES), 2-(trimethylammonium)ethyl methanethiosul-
fonate bromide (MTSET), and 2-ethylammonium methane-
thiosulfonate hydrobromide (MTSEA) were purchased from
Anatrace Inc. (Maumee, OH). NEM was purchased from
Sigma-Aldrich BV (Zwijndrecht, The Netherlands), and
AMdiS was purchased from Molecular Probes Europe BV
(Leiden, The Netherlands).
RESULTS
InactiVation of CitS with N-Ethylmaleimide. Transport
activity of CitS using [1,5-14C]-citrate as the substrate was
measured in right-side-out vesicles prepared from E. coli
ECOMUT2 harboring plasmid pBADCitS, which encodes
the wild type CitS protein. In the presence of a proton motive
force (pmf) generated by the artificial electron donor system
Asc/PMS, the membranes took up citrate at a initial rate of
3.5 nmol/min per mg of protein (Figure 2A, open circles).
As shown before (4), no uptake activity could be detected
in RSO membrane vesicles that were prepared from the host
cells that do not express CitS (not shown). Prior treatment
of the membranes containing CitS with 1 mM thiol reagent
N-ethylmaleimide (NEM) for 10 min resulted in 80%
inhibition of the citrate uptake rate (Figure 2A, solid circles).
Treatment with NEM for increasing amounts of times
revealed a half time of inactivation of 3 min, and eventually,
full inactivation (Figure 2B).
Identification of the ReactiVe Cysteine Residues. The CitS
protein contains five cysteine residues (CCCCC, see Figure
1). Two cysteine mutants were constructed, SSSCC and
CCCSS, in which the first three (Cys-278, Cys-317, and Cys-
347) and last two (Cys-398 and Cys-414) cysteine residues
were mutated into serine residues, respectively. E. coli
ECOMUT2 expressing the two mutants grew as dark blue
colonies on Simmons agar indicator plates indicative of
citrate uptake and metabolism. Uptake activity in RSO
membranes indicated that both mutants showed significant
citrate transport activity, while the expression levels as
FIGURE 2: Citrate uptake activity of wild type CitS. (A) [1,5-14C]-citrate uptake in RSO membrane vesicles containing wild type CitS
before (open circles) and after (solid circles) treatment with 1 mM NEM for 10 min. (B) Residual citrate uptake rate after treatment with
1 mM NEM for the indicated time. Initial rates were expressed as the percentage of the initial rate catalyzed by untreated CitS (3.5 nmol/
min per mg of protein).
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determined by Western blotting were similar as observed
for the wt protein. The specific activities of the CCCSS and
SSSCC mutants were 56 and 79% relative to the wild type,
respectively (not shown).
Treatment of mutant SSSCC with 1 mM NEM revealed
an inactivation pattern with a half time of about 2.5 min,
very similar to that observed for the wild type (Figure 3A).
In contrast, mutant CCCSS was quite insensitive to NEM;
the loss of activity was 20% after 20 min of incubation
(Figure 3B). The results show that the inactivation of wild
type CitS was mainly due to labeling of one or both of the
two cysteine residues located in loop Xa.
The specific activity of the two single cysteine mutants
SSSSC and SSSCS that were constructed next was 28 and
57% relative to wild type, respectively. Mutant SSSSC was
much more sensitive to NEM than observed for the wild
type and the SSSCC mutant. The half time of inactivation
was less than 1 min (Figure 3C). Interestingly, the cysteine
mutant SSSCS was inactivated by NEM much more slowly
resulting in about 50% residual activity after 20 min of
treatment (Figure 3D). Clearly, both cysteine residues are
accessible to NEM, and labeling results in inactivation of
the transporter. However, the reactivity in the two single
cysteine mutants, SSSCS and SSSSC, is not the same as in
the SSSCC mutant. The presence of Cys-398 reduces the
reactivity of Cys-414.
Accessibility of the Cysteines in CitS. AmdiS is a male-
imide derivative containing a bulky, negatively charged
group, and therefore, in contrast to NEM, membrane
impermeable. Treatment of membranes containing CCCCC
and SSSCC with AmdiS did not result in a significant
decrease of uptake activity (Figure 4).
The methanethiosulfonate (MTS) derivatives MTSEA,
MTSET, and MTSES represent thiol reactive reagents that
react with cysteine residues in proteins to form mixed
disulfides. They differ in size, membrane permeability, and
charge of the groups attached to the reactive MTS moiety.
MTSEA and MTSET are positively charged, whereas MT-
SES is negative. The reactivity of the reagents decreases in
the order MTSET > MTSEA > MTSES (28). Treatment of
RSO membrane vesicles expressing CitS and cysteine
mutants SSSCC and CCCSS for 20 min in the absence of
sodium ions, with 1 mM MTSEA, 2 mM MTSET, and 10
mM MTSES, resulted in significantly reduced uptake activity
for all the three reagents (Figure 4A). The same pattern of
inactivation was observed with RSO membranes containing
the SSSCC mutant, indicating that labeling of the two
cysteine residues in loop Xa was responsible for the
inactivation (Figure 4B). Membranes containing mutant
CCCSS were largely insensitive to MTSET and MTSES, but
the uptake activity was reduced down to 30% after treatment
with MTSEA (Figure 4C). MTSEA is known to effect the
FIGURE 3: Effect of NEM on the citrate uptake activity of cysteine mutants. Residual activity of the [1,5-14C]-citrate uptake after treatment
of RSO membrane vesicles containing CitS mutants SSSCC (A), CCCSS (B), SSSSC (C), and SSSCS (D) for the indicated time with
1 mM NEM. Residual activity was presented as the percentage of the initial rate catalyzed by untreated membranes.
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pmf generating system in RSO membranes (29), and it is
concluded that the CCCSS mutant itself is not sensitive to
treatment by MTS reagents. It follows, in addition, that the
high decrease of uptake activity by MTSEA observed in the
membranes containing the wild type and the SSSCC mutant,
in part, was due to the reduced capacity of the membranes
to generate proton motive force.
In conclusion, the cysteine residues in cytoplasmic loop
Xa are accessible to the small membrane impermeable MTS
reagents MTSET and MTSES but not to the bulky and
impermeable maleimide AmdiS, added at the periplasmic
side of the membrane.
Effect of Na+ on Uptake and InactiVation by Thiol
Reagents. Transport activity of the CitS protein is strictly
coupled to translocation of two sodium ions (1). The rate of
uptake of citrate in whole cells of E. coli expressing CitS
increased sigmoidally with increasing Na+ concentration.
Half of the maximal rate was obtained at a concentration of
3.5 mM Na+ at pH 6.0. In RSO membrane vesicles
containing CitS, a similar sigmoidal dependence was ob-
served (Figure 5, closed circles). The rate increased more
than proportional with Na+ concentrations up to 1 mM
(Figure 5B). Half of the maximal rate of citrate uptake was
obtained at a slightly lower Na+ concentration than observed
in whole cells (2 vs 3.5 mM, respectively). The very low
rate observed in the absence of added sodium ions confirms
that CitS activity is obligatorily coupled to the translocation
of sodium ions.
The inactivation of CitS by thiol reagents presented thus
far was performed in the absence of added sodium ions. The
presence of sodium ions had a dramatic effect on the
inactivation. Labeling of wild type CitS with 1 mM NEM
was prevented above concentrations of 25 mM Na+ (Figure
5A, open circles). Importantly, a plot of the residual activity
as a function of the Na+ concentration during NEM treatment
revealed the same sigmoidal shape as observed in the relation
between activity and Na+ concentration, indicating that it
takes two sodium ions to bind for the cysteine residues to
become insensitive to the alkylating reagent (Figure 5C). The
Na+ concentration yielding half of the full protection was 6
mM.
The protection of CitS against labeling by NEM in the
presence of sodium ions was also observed for the MTS
reagents. In the presence of 70 mM Na+, the residual
activities were between 80 and 90% for both MTSET and
MTSES under the condition of the experiment described in
Figure 4A (not shown). The protection by sodium ions
requires a reevaluation of the inactivation by MTSES in the
absence of added sodium ions (Figure 4A). MTSES comes
as the sodium salt (i.e., inactivation down to 35% was
obtained in the presence of 10 mM Na+), a concentration
that resulted in 70% protection against NEM labeling. It
follows that CitS is much more sensitive to labeling with
negatively charged MTSES than positively charged MTSET.
Protection by Citrate Against InactiVation by NEM.
Inactivation of wild type CitS with NEM in the absence and
presence of 3 mM Na+ was studied at increasing concentra-
tions of the substrate citrate. A small increase in residual
activity was observed in the presence of citrate concentrations
up to 10 mM when no sodium ions were added (Figure 6,
open circles). At a concentration of 3 mM Na+, inactivation
by NEM is still significant. Addition of citrate under these
conditions resulted in a marked protection against inactivation
by NEM. Maximal effect was obtained at a citrate concentra-
tion of about 6 mM where the residual activity was 75%.
Further increase of the citrate concentration had no further
effect on protection against NEM (Figure 6, solid circles).
In conclusion, protection by citrate against NEM inactivation
was observed only in the presence of sodium ions.
Effect of the Proton MotiVe Force on CitS InactiVation.
The effect of the proton motive force (pmf) on the labeling
efficiency of the cysteine residues in CitS was measured in
the absence of added sodium ions. Treatment of the
membranes at 30 °C in the absence of the proton motive
force with 0.3 mM NEM resulted in 50% reduction of the
initial citrate uptake rate. In the presence of the proton
gradient, the same treatment almost completely inactivated
CitS (Figure 7). In a control experiment using membrane
vesicles containing the CCCSS mutant, no difference was
observed between the two conditions (not shown). Appar-
ently, the presence of the pmf makes CitS much more
sensitive to NEM. In contrast, labeling with the membrane
FIGURE 4: Inactivation of CitS by various thiol reagents. RSO membrane vesicles containing wild type CitS (A) and the mutants SSSCC
(B) and CCCSS (C) were treated with the indicated thiol reagents after which the activity was measured and plotted as the percentage of
the rate obtained with untreated membranes. The reagents were used at concentrations of 1 mM NEM, 0.25 mM AmdiS, 1 mM MTSEA,
2 mM MTSET, and 10 mM MTSES. The bars represent the average and standard deviation obtained from at least three independent
measurements.
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impermeable MTS reagents, MTSET and MTSES, appeared
to be much less affected by the pmf. Also, the presence of
3 mM Na+ added as the counterion of the MTSES anion
did not appear to significantly change the effect of the pmf
on inactivation.
DISCUSSION
The CitS protein contains five cysteine residues, and all
are located in the C-terminal half of the transporter. Cys-
278 and Cys-347 are located in putative TMSs VII and IX,
respectively. Cys-317 is located in the cytoplasmic loop
between TMS VIII and IX and the two residues Cys-398
and Cys-414 in the cytoplasmic loop between TMS X and
XI (see Figure 1). Labeling of the latter two residues resulted
in inactivation of the transporter. Most of the cytoplasmic
loop between TMS X and XI forms together with the first
turn of putative TMS XI a stretch of about 40 residues that
is particularly well-conserved in the 2HCT family (region
Xa). Evidence is accumulating that this region is part of the
substrate translocation site. (i) Mutation of the conserved
arginine residue in the first turn of TMS XI dramatically
lowered the activity of the Na+-symporter CitS of K.
pneumoniae (unpublished), the H+-symporter CimH of B.
subtilis (16), and the exchanger CitP of L. mesenteroides
(19). (ii) The CimH mutant revealed a loss of affinity for
citrate and the CitP mutant for the dicarboxylate (S)-malate
but not for the monocarboxylate (S)-2-hydroxyisobutyrate,
strongly suggesting a direct interaction between the arginine
residue and the second carboxylate of dicarboxylate sub-
strates. (iii) Exchange of the C-terminal 46 residues, contain-
ing most of region Xa, between the exchangers CitP and
MleP exchanged the affinity for the monocarboxylates (S)-
mandalate and (S)-2-hydroxyisovaleriate (18). (iv) Labeling
of the cysteine residues in R420C and Q428C mutants of
CimH (20) and the SSSCS and SSSSC mutants of CitS (this
paper), all located in region Xa, resulted in inactivation of
the transporters. (v) Inactivation was prevented by the
presence of the substrate (CimH) or by both substrate and
co-ion (CitS).
Strong support for the significance of these observations
in terms of translocation mechanism follows from the
accessibility of region Xa, situated at the cytoplasmic face
of the membrane, from the periplasmic side of the membrane.
The small, negatively charged, membrane impermeable MTS
reagent MTSES was able to reach the cysteine residues in
the R420C and Q428C mutants of CimH of B. subtilis (20),
and here we show that the same is true for the endogenous
cysteine residues in region Xa of CitS of K. pneumoniae.
While the positively charged MTS-derivative MTSET did
not inactivate CimH under the conditions tested, it did
inactivate CitS albeit to a lower extent than MTSES. More
bulky, charged reagents such as AmdiS were without effect
with both transporters suggesting a clear size limit to the
access pathway. The relatively high reactivity with negatively
charged MTSES, which is somewhat obscured in the case
of CitS because of the protection by Na+ ions, has been
explained before by the resemblance of the molecular
properties of MTSES and citrate, the substrate of the
FIGURE 5: Effect of sodium ions on the uptake activity and
inactivation by NEM. (A) The initial rate of citrate uptake in RSO
membrane vesicles containing CitS (solid circles) and the residual
activity after treatment of the same membranes with 1 mM NEM
for 10 min (open circles). (B and C) Initial rates (B) and residual
activity (C) at low sodium ion concentrations. The experiments were
performed using low sodium KPi buffers (see Experimental
Procedures). The residual Na+ concentration in the absence of added
sodium ions was estimated to be about 2.5 íM.
FIGURE 6: Protection by citrate against inactivation by NEM. RSO
membranes containing CitS were treated with 1 mM NEM in the
absence (open circles) and presence of 3 mM Na+ (closed circles)
and the indicated concentrations of citrate. The residual activity
was measured after removal of citrate and plotted as the percentage
of an untreated sample.
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transporters (30). The access pathway to region Xa would
correspond to the substrate entrance pathway that has been
optimized for negatively charged substrates.
Transport activity of the CitS protein is strictly coupled
to the translocation of two sodium ions demonstrated both
in whole cells and RSO membrane vesicles (ref 1; this paper).
The protection of CitS by Na+ against inactivation by NEM
followed a similar relation with increasing Na+ concentration
linking the conversion to the protected state directly to a
transition between two catalytic states of the transporter. The
different affinities for Na+ obtained in the two types of
experiments (2 and 6 mM, respectively) are likely to reflect
the different conditions of the transporter in the two types
of experiments (i.e., presence vs absence of citrate, presence
vs absence of the pmf, and steady state vs equilibrium state).
The protection experiment demonstrates that both Na+ ions
bind to the transporter in the absence of the substrate citrate
(i.e., bound citrate is not part of the Na+ binding sites (5))
and that both Na+ ions have to bind to render the protein in
the protected state. The substrate citrate resulted in additional
protection of CitS against inactivation by the thiol reagents
but only in the presence of subsaturating concentrations of
Na+. Little protection was observed in the absence of added
Na+, strongly suggesting that citrate does not bind to the
transporter in the absence of Na+. The protection by citrate
at low concentrations of Na+ may be explained by an
increased affinity of the protein for Na+ upon citrate binding
or by a direct protection by the bound citrate molecule. The
close vicinity of the target cysteine residues and the
conserved arginine residue in TMS XI that is believed to
interact with the substrate would favor the latter possibility.
The concentration of citrate required to obtain protection
against NEM inactivation was 3 orders of magnitude higher
than the reported Km value for pmf driven citrate uptake in
RSO membrane vesicles (8.3 íM; (6)). Again, the different
apparent affinities are likely to be the result of the different
kinetic states of the transporter. During the NEM treatment,
in the presence of Na+ and citrate, CitS catalyzes equilibrium
exchange, and the observed affinity for citrate is an average
of the internal and external binding site affinities weighted
by the translocation equilibrium (31). Pmf driven uptake
represents an unidirectional transport mode for which the
(kinetic) affinity is more related to the affinity of the external
binding site. Similar differences between pmf driven uptake
and exchange modes of transport were observed for the well-
studied lactose transport protein LacY of E. coli (32).
In a recent study, the CitS molecule was studied by single-
molecule fluorescence spectroscopy (33). Cys-398 in SSSCS
was labeled with the fluorophores Alexaphluor 546/568 C5
maleimide, and the fluorescence of single molecules was
monitored. It was demonstrated that the presence of citrate
completely quenched the signal and that the quenching was
not affected by Na+ ions. It was concluded that citrate
binding resulted in a conformational change that would be
responsible for the quenching. These conclusions appear in
marked contradiction with our conclusions (i.e., Na+ binding
results in a conformational change in which the cysteine
residues are protected against thiol reagents and citrate is
effective only after Na+ binding). Clearly, the conformational
changes resulting in the fluorescence quenching and in the
thiol protected state are not likely to be the same. An
important difference between the experiments may be in the
state of the transporter molecule. In the fluorescence studies,
CitS was solubilized in detergent solution, while in this study
the protein is in its native environment of the cytoplasmic
membrane.
The present study suggests the following model for the
molecular properties of the catalytic states during turnover
of CitS. Residues in region Xa at the membrane/cytoplasm
interface are part of or in close vicinity to the citrate binding
site. In the absence of citrate and Na+, the transporter is in
a state in which the two cysteine residues in region Xa are
accessible from the periplasmic side of the membrane for
the small MTSET and MTSES ions. The coupling of fluxes
catalyzed by a symporter like CitS requires that in this
unloaded state, the binding site is alternately opened to both
sides of the membrane. It is likely that access by the MTS
derivatives reflects the site opened to the periplasm, while
inactivation by membrane permeable NEM reflects the site
opened to the cytoplasm. Importantly, despite the access
pathway for MTSES and MTSET, the binding site for citrate
would not be formed in this state. Binding of Na+ locks the
transporter in the conformation with the site opened to the
periplasm (or to the cytoplasm) to prevent leakage of Na+.
In this state, the transporter binds citrate, and the access
pathway for MTSES and MTSET is closed. In other words,
Na+ binding creates the citrate binding site at the membrane/
cytoplasm interface and makes the access pathway more
specific. This could be envisaged by a narrowing of the
translocation pore thereby bringing the residues that interact
with the substrate in the correct spatial arrangement. The
surprising thing is that in the unloaded state the transport
protein seems to be in an open, kind of loose state that
changes into a highly specific pore in the presence of Na+.
The presence of the pmf does not seem to have a significant
effect on the access pathway from the periplasmic side of
the membrane, neither in the presence or absence of
subsaturating concentrations of Na+. In contrast, attack from
FIGURE 7: Effect of the pmf on inactivation by thiol reagents. RSO
membrane vesicles containing CitS were treated at 30 °C with 0.3
mM NEM for 10 min (A), 1 mM MTSET for 20 min (B), and 3
mM MTSES for 20 min (C) in the presence and absence of a pmf
as indicated. Sodium ions were not present during the treatment,
except for MTSES that contains a stoichiometric amount of Na+
(3 mM). The pmf was generated by addition of ascorbate and PMS,
which was removed after the treatment by spinning the samples
(see Experimental Procedures). The residual activity was plotted
as the percentage of a sample not treated with thiol reagents and
represents the average and standard deviation from at least three
independent measurements.
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the cytoplasmic side of the membrane by NEM was
significantly more effective, suggesting that the effect of the
pmf may be restricted to changes in the domain formed by
the Xa region, possibly to the citrate binding site. At any
rate, binding of the Na+ co-ions and the pmf appear to have
quite different effects on the conformation of the transport
protein.
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